
Opinion|Videos|September 4, 2024
Safety and Efficacy of GnRHa Treatments in Central Precocious Puberty
The panel examines the efficacy and safety profiles of gonadotropin-releasing hormone analogue (GnRHa) treatments in managing Central Precocious Puberty.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are long-term efficacy and safety data associated with gonadotropin releasing hormone analogue (GnRHa) treatment?
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP publishes 2026 childhood and adolescent immunization schedule
2
FDA clears first at-home test to detect RSV, influenza, and COVID-19 in infants as young as 6 months
3
Genomic sequencing may transform newborn screening
4
AAP updates guidance on therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy
5




